Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Isospin asymmetry in the pseudospin dynamical symmetry.
Physical review letters·2001
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).
Annals of oncology : official journal of the European Society for Medical Oncology·2000
Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas.
Acta oncologica (Stockholm, Sweden)·1999
Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort.
European journal of cancer (Oxford, England : 1990)·2026
Timing of first-line palliative systemic therapy in metastatic esophagogastric adenocarcinoma: A population-based analysis & target trial emulation.
European journal of cancer (Oxford, England : 1990)·2026
Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study.
European journal of cancer (Oxford, England : 1990)·2026
Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary?
European journal of cancer (Oxford, England : 1990)·2026
The UK's radiotherapy workforce shortage: Reforming regulation to address the gap.
European journal of cancer (Oxford, England : 1990)·2026
A phase I, first-in-human dose-escalation and triple-negative breast cancer dose-expansion study of a TROP2-ADC F0024 (FDA018).
European journal of cancer (Oxford, England : 1990)·2026